Gene · 3363
Papers1,585
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,585
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drugs associated with cataract formation represent an unmet need in cataract research. | Front Med (Lausanne) | 2022 | 36045926 | PubTator, text mining | PubMed |
| Antipsychotics function as epigenetic age regulators in human neuroblastoma cells. | Schizophrenia (Heidelb) | 2022 | 36038613 | PubTator, text mining | PubMed |
| Region specific differential regulation of 5HT-5A and 5B receptor is associated with the difference in stress level between male and female rats. | Heliyon | 2022 | 36033311 | PubTator, text mining | PubMed |
| Human-Induced Pluripotent Stem Cell Technology: Toward the Future of Personalized Psychiatry. | J Pers Med | 2022 | 36013289 | PubTator, text mining | PubMed |
| Fenfluramine: A Review of Pharmacology, Clinical Efficacy, and Safety in Epilepsy. | Children (Basel) | 2022 | 36010049 | PubTator, text mining | PubMed |
| Pathophysiological Mechanisms of Antipsychotic-Induced Parkinsonism. | Biomedicines | 2022 | 36009557 | PubTator, text mining | PubMed |
| Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1. | Breast Cancer | 2022 | 36006564 | PubTator, text mining | PubMed |
| Effect of Vortioxetine on Cognitive Impairment in Patients With Major Depressive Disorder: A Systematic Review and Meta-analysis of Randomized Controlled Trials. | Int J Neuropsychopharmacol | 2022 | 35981958 | PubTator, text mining | PubMed |
| New investigational agents for the treatment of major depressive disorder. | Expert Opin Investig Drugs | 2022 | 35975761 | PubTator, text mining | PubMed |
| Serotonin system is partially involved in immunomodulation of Nile tilapia (Oreochromis niloticus) immune cells. | Front Immunol | 2022 | 35967362 | PubTator, text mining | PubMed |
| The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference. | Int J Mol Sci | 2022 | 35955946 | PubTator, text mining | PubMed |
| Statins Neuromuscular Adverse Effects. | Int J Mol Sci | 2022 | 35955495 | PubTator, text mining | PubMed |
| Serotonin Receptor Agonists in the Treatment of Migraine: A Meta-Analysis Considering Possible Connection with Paresthesia. | Ann Indian Acad Neurol | 2022 | 35936602 | PubTator, text mining | PubMed |
| Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia. | Adv Pharm Bull | 2022 | 35935056 | PubTator, text mining | PubMed |
| Identification of Potential Parkinson's Disease Drugs Based on Multi-Source Data Fusion and Convolutional Neural Network. | Molecules | 2022 | 35897954 | PubTator, text mining | PubMed |
| The molecular pathophysiology of depression and the new therapeutics. | MedComm (2020) | 2022 | 35875370 | PubTator, text mining | PubMed |
| Recent advances in chemistry and therapeutic potential of functionalized quinoline motifs - a review. | RSC Adv | 2022 | 35873320 | PubTator, text mining | PubMed |
| A randomized, double-blind, placebo controlled, phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of LB-102, a selective dopamine D2/3/5-HT7 inhibitor. | Psychopharmacology (Berl) | 2022 | 35841422 | PubTator, text mining | PubMed |
| Vortioxetine as adjunctive therapy in the treatment of schizophrenia. | Ther Adv Psychopharmacol | 2022 | 35833056 | PubTator, text mining | PubMed |
| The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation? | Int Clin Psychopharmacol | 2022 | 35815937 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3363/papers?page=14